Royal London Asset Management LTD Biogen Inc. Transaction History

Royal London Asset Management LTD

  • $39.4 Billion
  • Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Biogen Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 65,629 shares of BIIB stock, worth $9.89 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
65,629
Previous 69,572 5.67%
Holding current value
$9.89 Million
Previous $16.1 Million 21.12%
% of portfolio
0.03%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$189.07 - $236.8 $745,503 - $933,702
-3,943 Reduced 5.67%
65,629 $12.7 Million
Q2 2024

Aug 07, 2024
BUY
$190.52 - $236.72 $2.43 Million - $3.02 Million
12,751 Added 22.44%
69,572 $16.1 Million
Q1 2024

May 14, 2024
SELL
$212.02 - $267.71 $83,535 - $105,477
-394 Reduced 0.69%
56,821 $12.3 Million
Q4 2023

Feb 13, 2024
SELL
$222.59 - $267.94 $783,516 - $943,148
-3,520 Reduced 5.8%
57,215 $14.8 Million
Q3 2023

Nov 14, 2023
SELL
$253.3 - $285.89 $2.41 Million - $2.71 Million
-9,495 Reduced 13.52%
60,735 $15.6 Million
Q2 2023

Aug 11, 2023
SELL
$275.25 - $318.06 $7.2 Million - $8.32 Million
-26,145 Reduced 27.13%
70,230 $20 Million
Q1 2023

May 15, 2023
SELL
$256.56 - $292.34 $11.4 Million - $13 Million
-44,443 Reduced 31.56%
96,375 $26.8 Million
Q4 2022

Feb 09, 2023
SELL
$252.44 - $306.72 $3.71 Million - $4.51 Million
-14,693 Reduced 9.45%
140,818 $39 Million
Q3 2022

Nov 14, 2022
BUY
$194.69 - $268.46 $10 Million - $13.9 Million
51,613 Added 49.68%
155,511 $41.5 Million
Q2 2022

Aug 12, 2022
SELL
$187.54 - $223.02 $161,847 - $192,466
-863 Reduced 0.82%
103,898 $21.2 Million
Q1 2022

May 13, 2022
BUY
$193.77 - $244.14 $741,557 - $934,323
3,827 Added 3.79%
104,761 $22.1 Million
Q4 2021

Oct 18, 2022
SELL
$223.92 - $287.77 $1.47 Million - $1.89 Million
-6,572 Reduced 6.11%
100,934 $24.2 Million
Q4 2021

Jan 18, 2022
SELL
$223.92 - $287.77 $1.47 Million - $1.89 Million
-6,572 Reduced 6.11%
100,934 $24.2 Million
Q3 2021

Oct 18, 2022
SELL
$282.99 - $369.05 $982,541 - $1.28 Million
-3,472 Reduced 3.13%
107,506 $30.4 Million
Q3 2021

Nov 02, 2021
SELL
$282.99 - $369.05 $982,541 - $1.28 Million
-3,472 Reduced 3.13%
107,506 $30.4 Million
Q2 2021

Oct 18, 2022
BUY
$259.0 - $414.71 $1.83 Million - $2.94 Million
7,080 Added 6.81%
110,978 $38.5 Million
Q2 2021

Jul 14, 2021
SELL
$259.0 - $414.71 $1.57 Million - $2.52 Million
-6,069 Reduced 5.19%
110,978 $38.5 Million
Q1 2021

Oct 17, 2022
BUY
$242.95 - $284.63 $3.19 Million - $3.74 Million
13,149 Added 12.66%
117,047 $32.8 Million
Q1 2021

Apr 13, 2021
BUY
$242.95 - $284.63 $965,726 - $1.13 Million
3,975 Added 3.52%
117,047 $32.7 Million
Q4 2020

Jan 29, 2021
BUY
$236.26 - $355.63 $476,536 - $717,305
2,017 Added 1.82%
113,072 $27.7 Million
Q3 2020

Nov 04, 2020
SELL
$264.77 - $305.71 $523,450 - $604,388
-1,977 Reduced 1.75%
111,055 $31.4 Million
Q2 2020

Jul 31, 2020
SELL
$258.66 - $342.55 $2.19 Million - $2.9 Million
-8,474 Reduced 6.97%
113,032 $29.4 Million
Q1 2020

May 01, 2020
BUY
$268.85 - $341.04 $541,732 - $687,195
2,015 Added 1.69%
121,506 $38.4 Million
Q4 2019

Feb 05, 2020
SELL
$220.06 - $304.07 $530,784 - $733,416
-2,412 Reduced 1.98%
119,491 $35.4 Million
Q3 2019

Nov 12, 2019
SELL
$217.44 - $243.88 $214,395 - $240,465
-986 Reduced 0.8%
121,903 $28.4 Million
Q2 2019

Jul 31, 2019
SELL
$219.29 - $241.72 $269,507 - $297,073
-1,229 Reduced 0.99%
122,889 $28.7 Million
Q1 2019

Apr 30, 2019
BUY
$216.71 - $338.96 $2.03 Million - $3.18 Million
9,382 Added 8.18%
124,118 $0
Q4 2018

Jan 29, 2019
BUY
$278.5 - $352.75 $7.26 Million - $9.2 Million
26,068 Added 29.4%
114,736 $33.7 Million
Q3 2018

Nov 08, 2018
SELL
$293.51 - $383.83 $793,064 - $1.04 Million
-2,702 Reduced 2.96%
88,668 $0
Q2 2018

Sep 19, 2018
BUY
$257.52 - $306.91 $23.5 Million - $28 Million
91,370 New
91,370 $26.5 Million

Others Institutions Holding BIIB

# of Institutions
1,038
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email